ENOV

Enovis Corporation (NYSE:ENOV) is a medical technology company that emerged from a strategic transformation of Colfax Corporation in 2022. The company operates as a focused medical device manufacturer serving the orthopedic and musculoskeletal treatment market worldwide. Enovis develops, manufactures, and distributes medical products used by orthopedic specialists, surgeons, physical therapists, and other healthcare professionals to treat patients with conditions ranging from degenerative diseases to sports injuries. The company has grown significantly through strategic acquisitions, most notably the Lima Corporate acquisition in 2024, which substantially expanded its reconstructive joint surgery capabilities.